High-Throughput Genomic Technology in Research and Clinical Management of Breast Cancer. Molecular Signatures of Progression From Benign Epithelium to Metastatic Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr1528
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Discerning Clinical Responses in Breast Cancer Based on Molecular Signatures

American Journal of Pathology
Forensic MedicinePathology
2017English

Symptom Management in Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Benign Breast Disease: Toward Molecular Prediction of Breast Cancer Risk

2005English

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Genomic Signatures Predict the Immunogenicity of BRCA-deficient Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

High-Throughput Identification of Reference Genes for Research and Clinical RT-qPCR Analysis of Breast Cancer Samples

Journal of Clinical Bioinformatics
2013English

A Case of Metastatic Uterine Cancer From Breast Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2002English

Genomic Approaches in the Management and Treatment of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy